Litfulo 00069-0334
Generic: Ritlecitinib
Product NDC
00069-0334- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 6, 2023
- Listing Expires
- December 31, 2027
- Application
- NDA215830
Need to source Litfulo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ritlecitinib Tosylate | 50 mg/1 |
Drug Class
Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 3A Inhibitors [MoA]Janus Kinase 3 Inhibitors [MoA]
Packaging Options(1)
28 CAPSULE in 1 BOTTLE (0069-0334-28)